ClinicalTrials.gg
CompletedNCT01414998SenRepUpdated Mar 20, 2013

Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes

An interventional study of Stress Ball vs Nicotine-free E-Cigarette and Nicotine-free E-Cigarette vs De-nicotinised Cigarette in Nicotine Withdrawal, sponsored by Queen Mary University of London. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-03-20.

Sponsored by Queen Mary University of London · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

There are currently two sensorimotor replacement products which may be of benefit in smoking cessation: de-nicotinised cigarettes (denics) and electronic cigarettes (ECs), and the purpose of this project is to investigate whether these replacements can help to alleviate tobacco withdrawal symptoms in smokers, during a period of abstinence. This project will be separated into two studies, following the same design and procedures.

Study 1 will seek to confirm the importance of sensorimotor cues by comparing the efficacy of a nicotine-free EC in alleviating withdrawal symptoms, to a behavioural distraction tool (e.g. stress ball) which provides no smoking-related cues.

Study 2 will investigate whether sensorimotor replacements which are more proximal to smoking (i.e. Denics), will be more effective in alleviating withdrawal symptoms than a replacement which only delivers some of the conditioned sensorimotor cues (i.e. ECs).

The investigators hypothesise that the EC will be more effective at reducing withdrawal symptoms compared to the stress ball in Study 1. In Study 2, it is hypothesised that the Denic will be more effective than the EC.

02

Conditions studied

  • Nicotine Withdrawal
03

In context

Lead sponsor

Queen Mary University of London is the lead sponsor of 253 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years or over
  • Smokes at least 10 cigarettes per day
  • Smokes first cigarette within 1 hour of waking

Exclusion criteria

Exclusion Criteria:

  • pregnant or breastfeeding
  • acute psychiatric illness
  • currently enrolled in other research projects
  • current use of ECs or Denics
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Stress Ball

    This is the active comparator for study 1

    Behavioral: Stress Ball vs Nicotine-free E-Cigarette

  • Experimental
    De-nicotinised Cigarette

    This will be the experimental arm for study 2

    Behavioral: Nicotine-free E-Cigarette vs De-nicotinised Cigarette

  • Experimental
    Nicotine-free Electronic Cigarette (1)

    This will be the experimental arm for study 1

    Behavioral: Stress Ball vs Nicotine-free E-Cigarette

  • Active comparator
    Nicotine-free Electronic Cigarette (2)

    This will be the active comparator for study 2

    Behavioral: Nicotine-free E-Cigarette vs De-nicotinised Cigarette

Interventions

  • BehavioralStress Ball vs Nicotine-free E-Cigarette

    In a cross over design, participants will be randomly allocated to: 1. use a stress ball for 5 minutes during a 1 hour controlled experiment. They will also use the stress ball for one day outside of the study centre. 2. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre. One week later participants will complete the other arm.

  • BehavioralNicotine-free E-Cigarette vs De-nicotinised Cigarette

    In a cross over design, participants will be randomly allocated to: 1. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre. 2. smoke 1 de-nicotinised cigarette during a 1 hour controlled experiment. They will also be given a pack to smoke ad-libitum for one day outside of the study centre. One week later participants will complete the other arm.

06

What researchers measure

Primary outcomes

  1. Urge to smoke at 10 minutes post product use

    Urges to smoke will be measured at 10 minutes after use of products

    Time frame: 10 minutes

Secondary outcomes

  1. Tobacco withdrawal symptom ratings over 1 hour

    Change withdrawal ratings one hour after product use

    Time frame: 1 hour

  2. Tobacco withdrawal symptom ratings over one day

    Change in tobacco withdrawal symptom ratings over a day

    Time frame: 1 day

07

Study locations

1 site
  • Tobacco Dependence Research Unit
    London, E1 2JH, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2012, a primary completion of Mar 2013 and a completion of Mar 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 10, 2011
First posted
Aug 11, 2011
Start
May 2012
Primary completionActual
Mar 2013
CompletionActual
Mar 2013
Last update
Mar 20, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01414998
Responsible party
Dunja Przulj (Prinicipal Investigator, Queen Mary University of London) — Principal investigator
First posted
Aug 11, 2011
Start date
May 2012
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Mar 20, 2013

Study contacts

Dunja Przulj
principal investigator · Queen Mary University of London

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion